Balancing Thrombotic Events and Bleeding in Primary PCI
| Autor: | Shamir R. Mehta |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Emergency Medical Services medicine.medical_specialty medicine.medical_treatment Myocardial Infarction Revascularization Antithrombins Percutaneous Coronary Intervention Internal medicine Antithrombotic medicine Emergency medical services Humans cardiovascular diseases Myocardial infarction Thrombus Arterial injury business.industry Percutaneous coronary intervention General Medicine Hirudins medicine.disease Peptide Fragments Recombinant Proteins Surgery surgical procedures operative Conventional PCI Cardiology Female business |
| Zdroj: | New England Journal of Medicine. 369:2263-2265 |
| ISSN: | 1533-4406 0028-4793 |
| Popis: | Primary percutaneous coronary intervention (PCI) has become the preferred method of reperfusion for patients with ST-segment elevation myocardial infarction (STEMI) when the procedure can be performed promptly by experts. Anticoagulation is important in patients undergoing primary PCI because it prevents acute thrombus formation at the site of arterial injury and on PCI-related hardware.1 Major bleeding that is associated with antithrombotic therapy is independently associated with subsequent death and recurrent ischemic events, and this relationship may be causal.2,3 One approach to reduce bleeding is to use antithrombotic therapies with better safety profiles. In the Harmonizing Outcomes with Revascularization and Stents . . . |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|